Atamyo Therapeutics

Atamyo Therapeutics Focuses on Developing a New Generation of Safe and Effective Gene Therapies for Neuromuscular Diseases. As a Spin-off from Gene Therapy Pioneer Genethon, Atamyo Leverages the Unique Expertise of Genethon's Progressive Muscular Dystrophy Laboratory in AAV Gene Therapy and Muscular Dystrophy. Atamyo Embodies Its Commitment to Improving the Lives of Patients with Neuromuscular Diseases Through Long-Lasting Effective Treatments.